We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > product labels

News List

FDA Approves Supplemental New Drug Applications to Include New Data in Product Labels for Synjardy®, americanpharmaceuticalreview
January 06, 2017
The U.S. Food and Drug Administration has approved supplemental New Drug Applications for three type 2 diabetes medicines within the empagliflozin family to include data from the landmark EMPA-REG OUTCOME® trial.
U.S. FDA approves supplemental New Drug Applications to include landmark data in product labels for lilly
January 06, 2017
The U.S. Food and Drug Administration (FDA) approved supplemental New Drug Applications for three type 2 diabetes medicines within the empagliflozin family to include data from the landmark EMPA-REG OUTCOME® trial.